
On the sidelines of President Lula’s visit, Brazil’s National Institute of Industrial Property (INPI) and India’s Council of Scientific & Industrial Research exchanged an access agreement to India’s famed Traditional Knowledge Digital Library (TKDL). The instrument, formally handed over on 21 February 2026, gives Brazilian patent examiners full search rights to a 400,000-record database of Ayurvedic, Unani and folk-medicine formulations used to police biopiracy and wrongful patenting. While the pact is primarily an IP story, it also creates a new pathway for specialist mobility. Both agencies confirmed that they will launch a rotating fellowship that brings Brazilian examiners to New Delhi for six-month stints and embeds Indian TK experts in Rio de Janeiro’s patent offices. Participants will travel on newly issued G-1 research visas that waive labour-market tests and streamline Brazilian CPF registration.
Mobility managers who need hands-on assistance with the new paperwork should note that VisaHQ offers an end-to-end processing service for Brazil-bound research visas. Through its dedicated portal (https://www.visahq.com/brazil/), the firm can pre-check eligibility, arrange document legalization, and track CPF issuance, smoothing the path for both Brazilian and Indian examiners.
For life-science multinationals—and their mobility teams—the significance is two-fold. First, quicker prior-art checks in Brazil should shorten the time-to-market for plant-based pharmaceuticals. Second, staff engaged on patent drafting or defensive publication projects may qualify for the same fast-track visa, cutting compliance overhead. Legal departments should note that INPI plans to reciprocate by opening its own biodiversity database to Indian officials later this year, hinting at a larger ecosystem of cross-border examiner exchanges across the Global South. Companies with R&D hubs in São Paulo or Hyderabad should monitor forthcoming administrative circulars detailing visa quotas, stipend rules and family-member eligibility.
Mobility managers who need hands-on assistance with the new paperwork should note that VisaHQ offers an end-to-end processing service for Brazil-bound research visas. Through its dedicated portal (https://www.visahq.com/brazil/), the firm can pre-check eligibility, arrange document legalization, and track CPF issuance, smoothing the path for both Brazilian and Indian examiners.
For life-science multinationals—and their mobility teams—the significance is two-fold. First, quicker prior-art checks in Brazil should shorten the time-to-market for plant-based pharmaceuticals. Second, staff engaged on patent drafting or defensive publication projects may qualify for the same fast-track visa, cutting compliance overhead. Legal departments should note that INPI plans to reciprocate by opening its own biodiversity database to Indian officials later this year, hinting at a larger ecosystem of cross-border examiner exchanges across the Global South. Companies with R&D hubs in São Paulo or Hyderabad should monitor forthcoming administrative circulars detailing visa quotas, stipend rules and family-member eligibility.